COMP <GO>
CHRD vs CVX // EV/EBITDA & P/E VALUATION
Chord Energy Corporation (NASDAQ) VS. Chevron Corporation (NYSE) • 15-METRIC TALLY: CHRD 4
— CVX 8
▲ EV/EBITDA & P/E VALUATION LEADER: CVX
LAST: $153.63 (-0.28%) • MKT CAP: $8.40B
valuation
25.2x
LAST: $231.46 (+0.99%) • MKT CAP: $457.31B
valuation
21.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CHRD VS. CVX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CHRD | CVX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 80.00% | 41.30% | +38.70 | CHRD | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 1.70% | 5.80% | -4.10 | CVX | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 25.2x | 21.5x | +3.70 | CVX | /valuation <GO> |
| Free Cash Flow Yield | 21.67% | 5.61% | +16.06 | CHRD | /fcf-yield <GO> |
| Operating Margin | 4.00% | 8.10% | -4.10 | CVX | /operating-margins <GO> |
| Net Profit Margin | 0.90% | 6.70% | -5.80 | CVX | /net-margins <GO> |
| Revenue Growth (YoY) | -7.10% | -4.60% | -2.50 | CVX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 3.78% | 2.79% | +0.99 | CHRD | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.66 | 3.71 | -2.05 | CVX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.2 | 64.7 | -7.50 | CVX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.15 | 1.07 | +0.08 | CHRD | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 34.6x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $8.40B | $457.31B | -$448.91B | CVX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CHRD REV | CVX REV | CHRD GROSS % | CVX GROSS % | CHRD FCF | CVX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.88B | $184.43B | 80.0% | 41.3% | $1.82B | $25.64B |
| FY 2024 | $5.25B | $193.41B | 73.1% | 38.4% | $1.86B | $22.79B |
| FY 2023 | $3.90B | $196.91B | — | — | $1.64B | $26.75B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CHRD // BETA 1.15
CVX // BETA 1.07